Key to symbols
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
2.6. Nitrates, calcium-channel blockers and other antianginal drugs
2.6.4. Peripheral vasodilators and related drugs
Total Formulary
DEFIBROTIDE (intravenous infusion)
Restrictions:
Use for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy is restricted to specialist use.
NAFTIDROFURYL OXALATE
Prescribing Notes:
Treatment should be reassessed after three months and discontinued if of no benefit. There is poor evidence supporting vasodilator treatment and it is important that contributory risk factor treatments (such as antiplatelet and cholesterol-lowering therapies) are considered.